SHAYLA FAWCETT: Open Payments
NPI 1912358508 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 87 payments from 16 companies in 2025. Trend: 2023 $258 · 2024 $1,047 · 2025 $3,367
Food & beverage: $3,367
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $1,245 |
| Janssen Biotech, Inc. | 11 | $555 |
| Madrigal Pharmaceuticals | 12 | $500 |
| Phathom Pharmaceuticals, Inc. | 5 | $280 |
| Janssen Scientific Affairs, LLC | 3 | $181 |
| Lilly USA, LLC | 2 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $116 |
| CONMED Corporation | 1 | $108 |
| PFIZER INC. | 3 | $45 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
Products named: SKYRIZI, TREMFYA, REZDIFFRA, RINVOQ, VOQUEZNA, LINZESS, OMVOH, ENTYVIO.
Industry payments across WA — which companies pay providers there.
